Showing results (6551-6560 of 25,889) with videos related to

Sort By:
Pageof 2,589
Anticancer Research|April 27, 1999
Clinical evaluation of serum and immunohistochemical expression of SCC and CA19-9 in radiation therapy for cervical cancerA Abe, T Nakano, S Morita, et al.
Anticancer Research|April 27, 1999
Peritumoral vascular invasion in women with node-negative breast cancer, receiving no adjuvant therapyM P Mathoulin-Portier, P Meynard, M C Charton-Bain, et al.
Anticancer Research|April 27, 1999
TUM2-PK (pyruvate kinase type tumor M2), CA19-9 and CEA in patients with benign, malignant and metastasizing pancreatic lesionsH Cerwenka, R Aigner, H Bacher, et al.
Anticancer Research|April 27, 1999
The expression of proto-oncogene c-jun in human pancreatic cancerG Tessari, C Ferrara, A Poletti, et al.
Anticancer Research|April 27, 1999
Serum concentrations of VEGF and b-FGF in renal cell, prostate and urinary bladder carcinomasM Edgren, B Lennernäs, A Larsson, et al.
Anticancer Research|May 5, 1999
A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studiesL Li, Z Zhu, B Joshi, et al.
Anticancer Research|May 5, 1999
Treatment of experimental osteosarcoma tumors in rat by herpes simplex thymidine kinase gene transfer and ganciclovirJ L Charissoux, L Grossin, M J Leboutet, et al.
Anticancer Research|May 5, 1999
Three distinct roles for TGF-beta during intercellular induction of apoptosis: a reviewT Häufel, S Dormann, J Hanusch, et al.
Anticancer Research|May 5, 1999
Inhibition of xanthine oxidase by benzothiazinone analoguesS Y Sheu, C Y Lin, J D Wu, et al.
Anticancer Research|May 5, 1999
Neurotensin receptor-mediated inhibition of pancreatic cancer cell growth by the neurotensin antagonist SR 48692M C Herzig, W G Chapman, A Sheridan, et al.
Pageof 2,589